A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement
Kolobaric, Antonija, Hewlings, Susan J, Bryant, Corey, Colwell, Christopher S, R. D’Adamo, Christopher, Rosner, Bernard, Chen, Jeff, Pauli, Emily K
Published in Nutrients (30.08.2023)
Published in Nutrients (30.08.2023)
Get full text
Journal Article
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN™ for Improving Sleep
Kolobaric, Antonija, Saleska, Jessica, Hewlings, Susan J, Bryant, Corey, Colwell, Christopher S, D'Adamo, Christopher R, Chen, Jeff, Pauli, Emily K
Published in Pharmaceuticals (Basel, Switzerland) (24.07.2024)
Published in Pharmaceuticals (Basel, Switzerland) (24.07.2024)
Get full text
Journal Article
The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial
Saleska, Jessica Londeree, Bryant, Corey, Kolobaric, Antonija, D'Adamo, Christopher R, Colwell, Christopher S, Loewy, Derek, Chen, Jeff, Pauli, Emily K
Published in Journal of the American Nutrition Association (2024)
Published in Journal of the American Nutrition Association (2024)
Get more information
Journal Article
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer
Rich, Patricia, Mitchell, R Brian, Schaefer, Eric, Walker, Paul R, Dubay, John W, Boyd, Jason, Oubre, David, Page, Ray, Khalil, Mazen, Sinha, Suman, Boniol, Scott, Halawani, Hafez, Santos, Edgardo S, Brenner, Warren, Orsini, James M, Pauli, Emily, Goldberg, Jonathan, Veatch, Andrea, Haut, Mitchell, Ghabach, Bassam, Bidyasar, Savita, Quejada, Maria, Khan, Waseemullah, Huang, Kan, Traylor, Linda, Akerley, Wallace
Published in Journal for immunotherapy of cancer (01.10.2021)
Published in Journal for immunotherapy of cancer (01.10.2021)
Get full text
Journal Article
The Safety and Effectiveness of Commercially Available Cannabidiol Products for Health and Well-Being: A Randomized, Multi-Arm, Open-Label Waitlist-Controlled Trial
Saleska, Jessica Londeree, Pauli, Emily K., Rezvan, Panteha, Cobb, Olivia, Chen, Jeff, Thorogood, Pelin, Backonja, Miroslav, Colwell, Christopher S., Loewy, Derek, Russo, Ethan, Wolitzky-Taylor, Kate, Waalen, Jill, Vandrey, Ryan, Laird, Kelsey T.
Published in Integrative medicine reports (01.11.2022)
Published in Integrative medicine reports (01.11.2022)
Get full text
Journal Article
Real-world performance of blood-based host immune profiling in first-line immunotherapy treatment in advanced-stage non-small cell lung cancer
Mitchell, R. Brian, Rich, Patricia, Walker, Paul R., Schaefer, Eric S, Tan, Jiahuai, Nagajothi, Nagaprasad, Dubay, John W., Boyd, Jason Keith, Oubre, David N., Ikhlaque, Nadeem, Page, Ray D., Khalil, Mazen, Sinha, Suman, Halawani, Hafez, Boniol, S. Scott, Santos, Edgardo S., Orsini, James Michael, Pauli, Emily K., Akerley, Wallace L.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Combination of Umbralisib, Ublituximab, and Bendamustine Is Safe and Highly Active in Patients with Advanced Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Lunning, Matthew A., Bierman, Philip, Bociek, R. Gregory, Schreeder, Marshall T., Siddiqi, Tanya, Flowers, Christopher R, Cohen, Jonathon B., Blumel, Susan, Cutter, Kathy, Pauli, Emily K., Sportelli, Peter, Miskin, Hari P, Weiss, Michael S., Vose, Julie M.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A Phase I Trial of TGR-1202, a Next Generation Once Daily PI3K-Delta Inhibitor in Combination with Obinutuzumab Plus Chlorambucil, in Patients with Chronic Lymphocytic Leukemia
Mahadevan, Daruka, Pauli, Emily K., Cutter, Kathy, Dietz, Lee Ann, Sportelli, Peter, Miskin, Hari P., Schreeder, Marshall T.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Combination of Ublituximab, TGR-1202, and Bendamustine Demonstrates Significant Activity in Patients with Advanced DLBCL and Follicular Lymphoma
Lunning, Matthew, Bierman, Philip J, Bociek, R. Gregory, Schreeder, Marshall T., Blumel, Susan, Cutter, Kathy, Pauli, Emily K., Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Vose, Julie M
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Ublituximab, a Novel Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), in Combination with TGR-1202, a Next Generation Once Daily PI3kδ Inhibitor, Demonstrates Activity in Heavily Pre-Treated and High-Risk Chronic Lymphocytic Leukemia (CLL) and B-Cell Lymphoma
Lunning, Matthew A., Vose, Julie M., Schreeder, Marshall T., Fowler, Nathan, Nastoupil, Loretta J., Siddiqi, Tanya, Blumel, Susan, Pauli, Emily K., Cutter, Kathy, Tse, Warner, Miskin, Hari P., Sportelli, Peter, Weiss, Michael S., Vakkalanka, Swaroop, Viswanadha, Srikant, O’Brien, Susan
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Ublituximab + TGR-1202 Demonstrates Activity and a Favorable Safety Profile in Relapsed/Refractory B-Cell NHL and High-Risk CLL: Phase I Results
Lunning, Matthew A., Vose, Julie, Fowler, Nathan, Nastoupil, Loretta, Burger, Jan A., Wierda, William, Schreeder, Marshall T., Siddiqi, Tanya, Flowers, Christopher, Cohen, Jonathon B., Blumel, Susan, Miguel, Myra, Cutter, Kathy, Pauli, Emily K., Handy, Ryan, Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., O'Brien, Susan
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Ublituximab plus TGR-1202 activity and safety profile in relapsed/refractory B-cell NHL and high-risk CLL
Lunning, Matthew Alexander, Vose, Julie, Fowler, Nathan Hale, Nastoupil, Loretta J., Schreeder, Marshall T., Siddiqi, Tanya, Flowers, Christopher, Cohen, Jonathon Brett, Blumel, Susan, Miguel, Myra, Tse, Warner H, Pauli, Emily K., Cutter, Kathy, Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Vakkalanka, Swaroop V.S., Viswanadha, Srikant, O'Brien, Susan Mary
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Safety and activity of the chemotherapy-free triplet of ublituximab, TGR-1202, and ibrutinib in relapsed B-cell malignancies
Fowler, Nathan Hale, Nastoupil, Loretta J., Lunning, Matthew Alexander, Vose, Julie, Siddiqi, Tanya, Flowers, Christopher, Cohen, Jonathon Brett, Schreeder, Marshall T., Miguel, Myra, Blumel, Susan, Phye, Brianna, Tse, Warner H, Pauli, Emily K., Cutter, Kathy, Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Vakkalanka, Swaroop V.S., Viswanadha, Srikant, O'Brien, Susan Mary
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A phase I trial of ublituximab (TG-1101), a novel glycoengineered anti-CD20 monoclonal antibody (mAb) in B-cell non-Hodgkin lymphoma patients with prior exposure to rituximab
O'Connor, Owen A., Deng, Changchun, Amengual, Jennifer Effie, Khalil, Mazen Y., Schreeder, Marshall T., Mahadevan, Daruka, Nikolinakos, Petros, Sawas, Ahmed, Zain, Jasmine M., Patterson, Molly, Moon, Amber, Pauli, Emily K., Cutter, Kathy, Mackenzie, Michelle Ann, Brotherton, Marnie, Hodgson, Jamie, Cooper, Christen N, Sportelli, Peter, Miskin, Hari P., Farber, Charles Michael
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article